IADR Abstract Archives
Sub-epithelial connective tissue graft with or without enamel matrix derivative- a 3 –year prospective clinical study and patient-centred outcomes.
Objectives: The aim of this study was to compare the clinical and patient-centred outcomes of subepithelial connective tissue graft (CTG) with and without enamel matrix derivative (EMD) in the treatment of Class I-II Miller periodontal recession defects.
Methods: This prospective clinical study evaluated 80 patients for a 3- year follow up period in private periodontal practice. 144 teeth were divided into two groups: Test Group (CTG with EMD – 80 teeth) and Control Group (CTG only - 64 teeth). Recession (REC), Keratinized Tissue (KT) width and Pain Visual Analogue Scale (P-VAS) were measured and collected.
Results: Complete root coverage was achieved in 64.2% of the Test group and 52.9%% of the Control group. The REC in test group reduced significantly (4.57 ± 1.55 to .5 ± .56) when compared to control group (4.26 ± 1.33 to .92 ± .54) (p<.01). There is also significant increased in KT width in the test vs. the control group at 36th month (2.47 ± .58 vs. 1.72 ± .36) (p < .01). There was less pain reported on the first week of surgery in the test group using the Pain-Visual Analogue Scale (p < .01).
Conclusions: The addition of EMD appears to result in a more stable recession and higher amount keratinized tissue width 36 months after treatment. The adjunctive use of EMD also resulted in statistically significant less pain 7 days after the surgery.
Methods: This prospective clinical study evaluated 80 patients for a 3- year follow up period in private periodontal practice. 144 teeth were divided into two groups: Test Group (CTG with EMD – 80 teeth) and Control Group (CTG only - 64 teeth). Recession (REC), Keratinized Tissue (KT) width and Pain Visual Analogue Scale (P-VAS) were measured and collected.
Results: Complete root coverage was achieved in 64.2% of the Test group and 52.9%% of the Control group. The REC in test group reduced significantly (4.57 ± 1.55 to .5 ± .56) when compared to control group (4.26 ± 1.33 to .92 ± .54) (p<.01). There is also significant increased in KT width in the test vs. the control group at 36th month (2.47 ± .58 vs. 1.72 ± .36) (p < .01). There was less pain reported on the first week of surgery in the test group using the Pain-Visual Analogue Scale (p < .01).
Conclusions: The addition of EMD appears to result in a more stable recession and higher amount keratinized tissue width 36 months after treatment. The adjunctive use of EMD also resulted in statistically significant less pain 7 days after the surgery.